Paracetamol for Catheter Related Bladder Discomfort
THE EFFECT OF INTRAOPERATIVE PARACETAMOL ON CATHETER-RELATED BLADDER DISCOMFORT: A PROSPECTIVE, RANDOMISED, DOUBLE-BLIND STUDY
1 other identifier
interventional
64
1 country
1
Brief Summary
The insertion of an urinary catheter in a patient undergoing a surgical procedure, especially in urinary interventions, may lead to catheter-related bladder discomfort with varying degrees of severity during the postoperative period. Catheter-related bladder discomfort (CRBD) symptoms associated with indwelling urinary catheter are similar to overactive bladder symptoms such as discomfort in the suprapubic region, urinary urgency, frequency, burning sensation with or without urge incontinence. Paracetamol is a drug with proven efficiency for the management of mild and moderate postoperative pain. In this study, the investigators hypothesized to address the effect of single-dose intravenous paracetamol on postoperative CRBD following percutaneous nephrolithotomy surgery (PNL).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for phase_4
Started Oct 2008
Shorter than P25 for phase_4
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2009
CompletedFirst Submitted
Initial submission to the registry
July 25, 2012
CompletedFirst Posted
Study publicly available on registry
July 27, 2012
CompletedJuly 27, 2012
July 1, 2012
9 months
July 25, 2012
July 26, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Reducing of Catheter related bladder discomfort symptoms
CRBD was evaluated with a 4 point scale (1; no discomfort, 2; mild, revealed on questioning only, 3; moderate, stated by the patient without questioning, 4; severe, urinary urgency executed by behavioral responses, such as attempts to remove urinary catheter, restless extremity movements, verbal responses) at postoperatively 30th minutes, 1st, 2nd, 4th, 6th and 12th hours.
CRBD was evaluated at postoperatively 30th minutes, 1st, 2nd, 4th, 6th and 12th hours
Secondary Outcomes (1)
Assessment of CRBD symptoms by the evaluation of VAS, sedation scales and hemodynamic findings
at postoperatively 30th minutes, 1st, 2nd, 4th, 6th and 12th hours.
Study Arms (2)
Group Control (n=32):iv 1.5 ml/kg 0.9% NaCl
PLACEBO COMPARATORGroup Paracetamol(n=32):iv 15mg/kg paracetamol
ACTIVE COMPARATORThe patients were randomly divided into two groups: Group P (Paracetamol group, n=32) received intravenous 15mg/kg paracetamol during the surgery and Group C (Control Group, n=32) received intravenous 1.5 ml/kg 0.9% NaCl solution 30 minutes before the of surgery.At the end of the surgery, all patients had an nephrostomy catheter and the insertion site was infiltrated with 20 ml 0.25% bupivacaine infiltration for postoperative analgesia. Each patient received patient-controlled intravenous analgesia by meperidine (10 mg bolus, 20-minute lock-out, no infusion dose and 4 hour limit) for postoperative analgesia. All patients were planned to receive tenoxicam 20 mg intravenously as a rescue analgesic when visual analogue scale (VAS) was \>3.
Interventions
Eligibility Criteria
You may qualify if:
- ≥ 18 years of age,
- American Society of Anesthesiologists (ASA) Physical Status of I-II,
- undergoing PNL with urinary bladder catheter.
You may not qualify if:
- obesity (BMI \> 30),
- chronic opioid use,
- bladder outflow obstruction,
- benign prostatic hyperplasia, and
- overactive bladder (OAB) (frequency \> 3 times at night or \> 8 times within 24h).
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Pinar Ergenoglulead
Study Sites (1)
Baskent University School of Medicine Adana Teaching and Research Hospital
Adana, 01250, Turkey (Türkiye)
Related Publications (3)
Agarwal A, Yadav G, Gupta D, Singh PK, Singh U. Evaluation of intra-operative tramadol for prevention of catheter-related bladder discomfort: a prospective, randomized, double-blind study. Br J Anaesth. 2008 Oct;101(4):506-10. doi: 10.1093/bja/aen217. Epub 2008 Jul 24.
PMID: 18653496BACKGROUNDBinhas M, Motamed C, Hawajri N, Yiou R, Marty J. Predictors of catheter-related bladder discomfort in the post-anaesthesia care unit. Ann Fr Anesth Reanim. 2011 Feb;30(2):122-5. doi: 10.1016/j.annfar.2010.12.009. Epub 2011 Jan 31.
PMID: 21277735BACKGROUNDErgenoglu P, Akin S, Yalcin Cok O, Eker E, Kuzgunbay B, Turunc T, Aribogan A. Effect of intraoperative paracetamol on catheter-related bladder discomfort: a prospective, randomized, double-blind study. Curr Ther Res Clin Exp. 2012 Dec;73(6):186-94. doi: 10.1016/j.curtheres.2012.08.001.
PMID: 24653520DERIVED
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Baskent University School of Medicine Adana Teaching and Research Hospital
Study Record Dates
First Submitted
July 25, 2012
First Posted
July 27, 2012
Study Start
October 1, 2008
Primary Completion
July 1, 2009
Study Completion
November 1, 2009
Last Updated
July 27, 2012
Record last verified: 2012-07